These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27513562)

  • 41. Epidemiology and outcome of acute pancreatitis in end-stage renal disease dialysis patients: a 10-year national cohort study.
    Chen HJ; Wang JJ; Tsay WI; Her SH; Lin CH; Chien CC
    Nephrol Dial Transplant; 2017 Oct; 32(10):1731-1736. PubMed ID: 28088773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
    Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
    JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and predictors of myocardial infarction after kidney transplantation.
    Lentine KL; Brennan DC; Schnitzler MA
    J Am Soc Nephrol; 2005 Feb; 16(2):496-506. PubMed ID: 15615820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis.
    Schamroth Pravda M; Cohen Hagai K; Topaz G; Schamroth Pravda N; Makhoul N; Shuvy M; Benchetrit S; Assali A; Pereg D
    Am J Nephrol; 2020; 51(8):635-640. PubMed ID: 32702703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis.
    Roh JH; Kim YG; Kim D; Park S; Park KS; Kim M; Hwang KW; Hwang W; Park GM; Lee JH
    Sci Rep; 2024 Jun; 14(1):14679. PubMed ID: 38918543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of and Fatality from Acute Pancreatitis in Long-Term Hemodialysis and Peritoneal Dialysis Patients.
    Wang IK; Lai SW; Lai HC; Lin CL; Yen TH; Chou CY; Chang CT; Huang CC; Sung FC
    Perit Dial Int; 2018; 38(1):30-36. PubMed ID: 29097488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.
    Jørgensen CH; Gislason GH; Andersson C; Ahlehoff O; Charlot M; Schramm TK; Vaag A; Abildstrøm SZ; Torp-Pedersen C; Hansen PR
    Cardiovasc Diabetol; 2010 Sep; 9():54. PubMed ID: 20843380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
    Yen FS; Hwu CM; Liu JS; Wu YL; Chong K; Hsu CC
    Ann Intern Med; 2024 Jun; 177(6):693-700. PubMed ID: 38684099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
    Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Adolescent Hypertension With Future End-stage Renal Disease.
    Leiba A; Fishman B; Twig G; Gilad D; Derazne E; Shamiss A; Shohat T; Ron O; Grossman E
    JAMA Intern Med; 2019 Apr; 179(4):517-523. PubMed ID: 30801616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
    Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims).
    Faridi KF; Bhalla N; Atreja N; Venditto J; Khan ND; Wilson T; Fonseca E; Shen C; Yeh RW; Secemsky EA
    Am J Cardiol; 2021 Jul; 151():70-77. PubMed ID: 34053629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis - A retrospective propensity score-matched study.
    Sun CY; Sung JM; Wang JD; Li CY; Kuo YT; Lee CC; Wu JL; Chang YT
    PLoS One; 2019; 14(10):e0223336. PubMed ID: 31574134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.
    Huang KW; Leu HB; Luo JC; Chan WL; Hou MC; Lin HC; Lee FY; Kuan YC
    Dig Dis Sci; 2014 Apr; 59(4):807-13. PubMed ID: 24318806
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.